Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
LSE:0A87
Takeda Pharmaceutical Co Ltd
LSE:0A87
Price:
14.4183
USD
2.27%
Market Closed
Market Cap:
$23.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Takeda Pharmaceutical Co Ltd
LSE:0A87
|
JP |
|
C
|
China Overseas Land & Investment Ltd
F:CPP
|
HK |
Wall St Price Targets
0A87 Price Forecast
Based on 18 analysts
Based on 18 analysts
+48% Upside
from
$14.4183
today
Takeda Pharmaceutical Co Ltd (0A87)’s 12-month stock price forecast through November 2026 has a consensus target of $21.3711, implying 48% upside. The forecast is based on price targets from 18 Wall Street analysts.
0A87 Analyst Rating
No ratings yet
No ratings yet
Takeda Pharmaceutical Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0A87's stock price target?
Price Target
21.3711
USD
21.3711
USD
According to Wall Street analysts, the average 1-year price target for 0A87 is 21.3711 USD with a low forecast of 16.8048 USD and a high forecast of 24.5879 USD.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
-24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is -24%.